PRESS RELEASE: LivMD, the Revolutionary Therapeutic Low Intensity Vibration Device treats Osteoporosis and available in Southern Africa from World Osteoporosis Day, 20 October 2015.


(Bloemfontein, South Africa – October 12, 2015)


Kriel Technology Group (Pty) Ltd introduces the LivMD to Southern Africa.

Fighting conditions that come with aging such as bone, joint and muscle issues are large priorities for many people. LivMD, is a product that has had great success using therapeutic vibration to treat these issues in the USA and the LivMD is not another “flavour of the month” exercise that will end up in your garage. Recently, the developers of LivMD, Marodyne Medical announced the product has been approved for export to South Africa in a breakthrough for innovative health care in the USA, Europe and Africa.


Kriel Technology Group, a distributor of “game-changer” technologies is pleased to announce that the LivMD is now available in Sub-Saharan Africa. The LivMD is the only vibration device that complies with the limits recommended for human tolerance by ISO 2631 and OSHA standards.

By contrast, Whole Body Vibration (WBV) is well beyond these limits and may be dangerous to use, especially for the injured or elderly.

Treating musculoskeletal conditions can often be a challenge. One method which is becoming more popular among medical professionals is using therapeutic vibration. Biomedical research and development company Marodyne Medical, along with their partners at Stony Brook University (New York, USA) have been leaders in the United States in this area, with their therapeutic low intensity vibration device LivMD. The company recently announced after great success in the United States, the LivMD was recently approved for export to all of the European Union for treatment of Osteoporosis and other musculoskeletal conditions. The CE mark makes the experience of the LivMD available to us here in Southern Africa.

“We are extremely excited about the opportunity to offer our customers in Africa a technology that has the potential to improve a myriad of musculoskeletal conditions,” commented Dr Clinton Rubin, Marodyne Chief Scientific Officer and Chair of Biomedical Engineering at Stony Brook University. “LivMD is a remarkable device developed from 30 years of research.”
According to Kriel Technology Group and Marodyne Medical some of the uses the LivMD has been approved for in the EU and Southern Africa include: Safe and effective treatment of osteoporosis; relief of minor aches and pains; restores range of motion to joints; improves circulation and lymphatic drainage; to name just a few of the device's indications for use.

LivMD’ s low intensity therapeutic vibration technology was developed over three decades ago at New York's Stony Brook University using funding from NASA, NIH and the US Army. The LivMD is the only device of its kind. It has become a popular therapy tool used by seniors, athletes, those with flexibility issues, the injured, and many more.

Feedback from the medical world has been very positive.

Stephan Becker, MD, recently stated, “I am very much looking forward to being able to offer Marodyne’ s LivMD (Low Intensity Vibration Medical Device) to my patients through our clinics in Austria, Spain, Korea, France and Finland.”


Notes to Editors

• The LivMD is available for purchase from Kriel Technology Group and more information is available at www.ktgroup.co.za under the medical tab - click on “Physiotherapy”.

About Marodyne Medical

Marodyne Medical, LLC is a research and development company, specializing in safe intervention for illness, disease and injury.

Marodyne Medical’s research has been led by Dr Clinton Rubin, Marodyne Medical chief scientific officer, distinguished professor and chair for the Department of Biomedical Engineering at SUNY, in collaboration with Marodyne Medical Scientific Board, comprised of scientists, professors and thought leaders in the low-intensity vibration sector.

Marodyne Medical has recently established the efficacy of low-intensity vibration to safely promote overall health and wellness.

About Kriel Technology Group

Kriel Technology Group is a new diversified player in the technology market covering Automotive, Agriculture, Food Technology, Medical/Life Style and Retail sectors. A close working relationship with its partners and customers in these fields, enables Kriel Technology Group to introduce “game – changer” solutions to professionals and consumers to increase productivity and improve the life quality of their customers.

Media Contacts

Kriel Technology Group
Gerhard Kriel
Managing Director
M +27 (0) 79 1207 650
E gerhard@ktgroup.co.za